Different In Vitro Drug Susceptibility Profile of Plasmodium falciparum Isolates from Two Adjacent Areas of Northeast Myanmar and Molecular Markers for Drug …
M Duan, Y Bai, S Deng, Y Ruan, W Zeng, X Li… - Tropical Medicine and …, 2022 - mdpi.com
… to chloroquine and pyrimethamine but relatively sensitive to … and used for in vitro drug
assay and genotyping [13]. Frozen … first ACT introduced, but its efficacy steadily declined in the …
assay and genotyping [13]. Frozen … first ACT introduced, but its efficacy steadily declined in the …
Malaria chemoprevention and drug resistance: a review of the literature and policy implications
CV Plowe - Malaria Journal, 2022 - Springer
… Pyrimethamine and other antifolates such as proguanil (via its metabolite cycloguanil) and
trimethoprim target P… those that rely on the antifolate drug sulfadoxine-pyrimethamine (SP). In …
trimethoprim target P… those that rely on the antifolate drug sulfadoxine-pyrimethamine (SP). In …
… implementation, effect on malaria incidence in a context of development of P. falciparum resistant genotypes with potential reduction of the effectiveness in western …
S Nikiema, I Soulama, S Sombié, AM Tchouatieu… - 2022 - researchsquare.com
… isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but
not … genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected …
not … genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected …
Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an …
EN Muthoka, K Usmael, SM Embaye, A Abebe… - Malaria Journal, 2023 - Springer
… dhfr mutant with a double dhps mutant is a useful predictor of clinical SP treatment failure and
results in limited efficacy … in infants with sulfadoxine-pyrimethamine (SP-IPTi) should not be …
results in limited efficacy … in infants with sulfadoxine-pyrimethamine (SP-IPTi) should not be …
An overview of drug resistance in protozoal diseases
R Capela, R Moreira, F Lopes - International journal of molecular …, 2019 - mdpi.com
… biomarkers and therapeutic efficacy studies in malaria endemic … resistance to
sulfadoxine-pyrimethamine (SP) [26,39]. … -phenyl side chain such as pyrimethamine and …
sulfadoxine-pyrimethamine (SP) [26,39]. … -phenyl side chain such as pyrimethamine and …
Recent advances in transmission-blocking drugs for malaria elimination
… used in combination with sulfadoxine-pyrimethamine (750 mg … trial that involved children
of Kenya, Senegal and Gabon, … drugs pyrimethamine and cycloguanil. Studies have shown …
of Kenya, Senegal and Gabon, … drugs pyrimethamine and cycloguanil. Studies have shown …
[PDF][PDF] Esther Nthenya Muthoka1, 2, Kedir Usmael1, 3, Saba Mehari Embaye1, Abigiya Abebe1, 4, Tigist Mesfin1, 5, Dorothy Kazembe1, 6, Mediha Ahmedin1, 7, Stella …
T Manyazewal - 2023 - academia.edu
… of clinical SP treatment failure and results in limited efficacy of SP-… with sulfadoxinepyrimethamine
(SP-IPTi) should not be … of Plasmodium falciparum to sulphadoxine/pyrimethamine in …
(SP-IPTi) should not be … of Plasmodium falciparum to sulphadoxine/pyrimethamine in …
[图书][B] Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019)
World Health Organization - 2020 - books.google.com
… sulfadoxine-pyrimethamine TES therapeutic efficacy studies … report from Cambodia of
Plasmodium falciparum parasite with … can also represent genotypes arising de novo but not being …
Plasmodium falciparum parasite with … can also represent genotypes arising de novo but not being …
[图书][B] Drug Development for Malaria: Novel Approaches for Prevention and Treatment
P Kendrekar - 2022 - books.google.com
… an active metabolite called cycloguanil pamoate. Mechanism of … Pyrimethamine and related
compounds inhibit the step … action, and widespread use of sulfadoxine/pyrimethamine (SP) …
compounds inhibit the step … action, and widespread use of sulfadoxine/pyrimethamine (SP) …